Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb

被引:30
作者
Melotti, P [1 ]
Calabretta, B [1 ]
机构
[1] THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, DEPT MICROBIOL & IMMUNOL, PHILADELPHIA, PA 19107 USA
关键词
D O I
10.1182/blood.V87.6.2221.bloodjournal8762221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To provide insight into the mechanisms by which c-myb regulates hematopoiesis, we analyzed the expression of markers for multiple hematopoietic lineages in differentiating parental embryonic stem (ES) cells and in ES cells transfected with c-myb or with a mutant c-myb deficient in DNA binding and assessed the ability of these cells to undergo hematopoietic commitment and colony formation. Undifferentiated ES cells transfected with intact c-myb, but not cells transfected with mutant c-myb, expressed CD34, c-kit, GATA1, and flt3 mRNA as well as surface CD34, c-kit, and flt3 product. In contrast, the kinetics of GATA-2 mRNA expression was identical in parental and Myb transfected ES cells. Transient expression assays suggested transactivation of gene expression dependent on interaction with Myb binding sites in the CD34 and GATA1 5' flanking regions. Undifferentiated parental and c-myb mutant transfected ES cells were not clonogenic, whereas c-myb transfectants formed erythromyeloid colonies in methylcellulose cultures in the absence of added hematopoietic growth factors and, at higher frequency, in the presence of kit and flt-3 ligands. Colony formation was suppressed by treatment with antisense oligodeoxynucleotides specifically downregulating c-kit and fit-3 expression. These findings indicate that c-myb regulates hematopoietic commitment and progenitor cell proliferation and differentiation through the activation of certain genes that define the stem/progenitor cell compartment. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2221 / 2234
页数:14
相关论文
共 65 条
[1]   AN OLIGOMER COMPLEMENTARY TO C-MYB-ENCODED MESSENGER-RNA INHIBITS PROLIFERATION OF HUMAN MYELOID-LEUKEMIA CELL-LINES [J].
ANFOSSI, G ;
GEWIRTZ, AM ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3379-3383
[2]   TRANSACTIVATION OF ERYTHROID TRANSCRIPTION FACTOR GATA-1 BY A MYB-ETS-CONTAINING RETROVIRUS [J].
AURIGEMMA, RE ;
BLAIR, DG ;
RUSCETTI, SK .
JOURNAL OF VIROLOGY, 1992, 66 (05) :3056-3061
[3]   MURINE MYB PROTOONCOGENE MESSENGER-RNA - CDNA SEQUENCE AND EVIDENCE FOR 5' HETEROGENEITY [J].
BENDER, TP ;
KUEHL, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (10) :3204-3208
[4]   ANTIGEN CD34+ MARROW-CELLS ENGRAFT LETHALLY IRRADIATED BABOONS [J].
BERENSON, RJ ;
ANDREWS, RG ;
BENSINGER, WI ;
KALAMASZ, D ;
KNITTER, G ;
BUCKNER, CD ;
BERNSTEIN, ID .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) :951-955
[5]  
BERENSON RJ, 1991, BLOOD, V77, P1717
[6]  
BRANDT J, 1992, BLOOD, V79, P634
[7]   THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM [J].
BURGESS, TL ;
FISHER, EF ;
ROSS, SL ;
BREADY, JV ;
QIAN, YX ;
BAYEWITCH, LA ;
COHEN, AM ;
HERRERA, CJ ;
HU, SSF ;
KRAMER, TB ;
LOTT, FD ;
MARTIN, FH ;
PIERCE, GF ;
SIMONET, L ;
FARRELL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4051-4055
[8]  
BURN TC, 1992, BLOOD, V80, P3051
[9]  
CALABRETTA B, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P225
[10]   NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS MANIFEST DIFFERENTIAL SENSITIVITY TO INHIBITORY EFFECTS OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - AN INVITRO STUDY RELEVANT TO BONE-MARROW PURGING [J].
CALABRETTA, B ;
SIMS, RB ;
VALTIERI, M ;
CARACCIOLO, D ;
SZCZYLIK, C ;
VENTURELLI, D ;
RATAJCZAK, M ;
BERAN, M ;
GEWIRTZ, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2351-2355